A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study

Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database

(2021) Yadong Wang et al.   BMC CANCER

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

(2020) Jonathan W Goldman et al.   LANCET ONCOLOGY

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

(2019) Luis Paz-Ares et al.   LANCET

Development and Validation of a Nomogram Prognostic Model for Small-Cell Lung Cancer Patients

(2018) Shidan Wang et al.   Journal of Thoracic Oncology

Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer

(2017) Hai-Fan Xiao et al.   Oncotarget

Nomogram prediction for the survival of the patients with small cell lung cancer

(2017) Hui Pan et al.   Journal of Thoracic Disease

A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients

(2016) Fanrong Zhang et al.   ANNALS OF SURGICAL ONCOLOGY

SCLC–State of the Art and What Does the Future Have in Store?

(2016) Kathrin Kahnert et al.   Clinical Lung Cancer

Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)

(2016) Anna Sophie Berghoff et al.   JOURNAL OF NEURO-ONCOLOGY

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

(2016) Sarah B Goldberg et al.   LANCET ONCOLOGY

Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer

(2015) Wenhua Liang et al.   JOURNAL OF CLINICAL ONCOLOGY

Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base

(2015) Susan E. Combs et al.   Journal of Thoracic Oncology

Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers

(2015) Dong Xie et al.   Journal of Thoracic Oncology

A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients

(2015) Young-Woong Won et al.   LUNG CANCER

Comprehensive genomic profiles of small cell lung cancer

(2015) Julie George et al.   NATURE

Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy

(2015) Dan Su et al.   PLoS One

Risk factors for brain metastases in completely resected small cell lung cancer: a retrospective study to identify patients most likely to benefit from prophylactic cranial irradiation

(2014) Hui Zhu et al.   Radiation Oncology

Stereotactic radiosurgery alone for small cell lung cancer: a neurocognitive benefit?

(2014) Eric Ojerholm et al.   Radiation Oncology

Nomogram Predicting Long-Term Survival After D2 Gastrectomy for Gastric Cancer

(2012) Dong-Seok Han et al.   JOURNAL OF CLINICAL ONCOLOGY

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

(2012) Kim Margolin et al.   LANCET ONCOLOGY

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

(2012) Charles M Rudin et al.   NATURE GENETICS

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

(2012) Martin Peifer et al.   NATURE GENETICS

Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer

(2010) Nathan R. Foster et al.   CANCER

Prognostic Factors for Survival in Extensive Stage Small Cell Lung Cancer (ED-SCLC): The Importance of Smoking History, Socioeconomic and Marital Statuses, and Ethnicity

(2010) Sai-Hong Ignatius Ou et al.   Journal of Thoracic Oncology

Predicting individual outcomes after radical cystectomy: an external validation of current nomograms

(2009) Dirk Zaak et al.   BJU INTERNATIONAL

How To Build and Interpret a Nomogram for Cancer Prognosis

(2008) Alexia Iasonos et al.   JOURNAL OF CLINICAL ONCOLOGY